ArticleNature immunology2020

Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.

Michael D Crowther et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.